Shridar Ganesan
Department of Hematology & Medical Oncology, Rutgers Cancer Institute of New Jersey, NJ.

Last Updated On 9/9/2024 11:00:30 PM
This is a disclosure report of the user financial relationships with for-profit health care companies.
All relationships are considered compensated unless otherwise noted. Relationships are self-held unless otherwise noted.

Employment
Company: Merck
Recipient: An Immediate Family Member

Leadership
No Relationships to Disclose

Stock and Other Ownership Interests
Company: Merck
Recipient: An Immediate Family Member
Company: Ibris
Recipient: You
Company: Inspirata
Recipient: You
Company: Silagene
Recipient: You

Honoraria
No Relationships to Disclose

Consulting or Advisory Role
Company: Inspirata
Recipient: You
Company: Novartis
Recipient: You
Company: Roche
Recipient: You
Company: Foghorn Therapeutics
Recipient: You
Company: Foundation Medicine
Recipient: You
Company: Merck Sharp & Dohme
Recipient: You
Company: Silagene
Recipient: You
Company: EQRx
Recipient: You
Company: EMD Serono
Recipient: You
Company: KayoThera
Recipient: You
Company: Ipsen
Recipient: You

Speakers' Bureau
No Relationships to Disclose

Research Funding
Company: M2Gen
Recipient: Your Institution
Company: Gandeeva Therapeutics
Recipient: Your Institution

Patents, Royalties, Other Intellectual Property
Please describe: I hold 2 patents for digital imaging that may be lisenced to Ibris, inc and Inspirata, Inc.
Recipient: You

Expert Testimony
No Relationships to Disclose

Travel, Accommodations, Expenses
No Relationships to Disclose

Other Relationship
Company: NCI/NIH
Recipient: You
Company: NCI/NIH
Recipient: You

(OPTIONAL) Uncompensated Relationships
No Relationships to Disclose

(OPTIONAL) Open Payments Link
not answered